CompaniesCardium Therapeutics

Cardium Therapeutics

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

4

As Collaborator

1

Total Enrollment

967

By Phase

PHASE3: 2PHASE2: 1PHASE2/PHASE3: 2

By Status

COMPLETED: 2UNKNOWN: 2TERMINATED: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT00346437
NCT00185263
NCT00438867
NCT01550614
Hover over trial bars to see details

Recent Trials

NCT01550614Lead Sponsor
Efficacy and Safety of Ad5FGF-4 for Myocardial Ischemia in Patients With Stable Angina Due to Coronary Artery Disease
PHASE3Terminated
11 participants
Started: Mar 31, 2012
NCT00493051Collaborator
Phase 2b Study of GAM501 in the Treatment of Diabetic Ulcers of the Lower Extremities
PHASE2Completed
124 participants
Started: Nov 30, 2007 · Completed: Dec 31, 2009
NCT00438867Lead Sponsor
Angiogenesis in Women With Angina Pectoris Who Are Not Candidates for Revascularization
PHASE3Unknown
300 participants
Started: May 31, 2007
NCT00185263Lead Sponsor
Safety and Efficacy of Intracoronary Ad5FGF-4 in Patients With Stable Angina
PHASE2/PHASE3Unknown
116 participants
Started: Mar 31, 2002 · Completed: Nov 30, 2008
NCT00346437Lead Sponsor
Efficacy and Safety of Intracoronary Ad5FGF-4 in Patients With Stable Angina (AGENT-3)
PHASE2/PHASE3Completed
416 participants
Started: Oct 31, 2001 · Completed: Nov 30, 2008
Cardium Therapeutics | Biotech Hunter | Biotech Hunter